Manulife (Manufacturers Life Insurance)
BCAX

Manulife (Manufacturers Life Insurance)’s Bicara Therapeutics BCAX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Sell
90,285
-8,633
-9% -$149K ﹤0.01% 1536
2025
Q4 		$1.6M Sell
98,918
-27,884
-22% -$476K ﹤0.01% 1626
2025
Q3 		$2M Buy
126,802
+1,019
+0.8% +$11.4K ﹤0.01% 1516
2025
Q2 		$1.17M Buy
125,783
+57,222
+83% +$682K ﹤0.01% 1748
2025
Q1 		$893K Buy
68,561
+39,423
+135% +$524K ﹤0.01% 1862
2024
Q4 		$508K Buy
29,138
+6,279
+27% +$131K ﹤0.01% 2232
2024
Q3 		$582K Buy
+22,859
New +$583K ﹤0.01% 2198

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BCAX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Bicara Therapeutics (BCAX) stake by 8.7% in Q1 2026, selling an estimated $149K and leaving 90,285 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

Manulife (Manufacturers Life Insurance) first reported a position in BCAX in Q3 2024 and has held it in 7 quarters since. The position peaked at $2M in Q3 2025. 146 funds tracked by Wall St. Rank hold BCAX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 90,285 shares of Bicara Therapeutics worth $1.8M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 8,633 Bicara Therapeutics shares in Q1 2026, an estimated $149K.
  • Bicara Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1536 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Bicara Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Bicara Therapeutics position peaked at $2M in Q3 2025.
  • 146 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.